Prostate cancer and active surveillance
Related Experiment Video
Updated: Jul 4, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
1Department of Urology, Malmö University Hospital, Malmö , Sweden.
Abstract:
This review outlines the different treatment options in localized prostate cancer. This information can be considered alongside other important factors, such as the individual patient's values and situation as well as the potential impact of treatment on his quality of life, in the treatment decision-making process. Taking all these factors into consideration, the data support active surveillance as an appropriate choice in patients with well or moderately differentiated, low-volume prostate cancer who have a life expectancy of less than 10 years. Men with higher-grade tumors and longer life expectancy may be at excess risk of death from prostate cancer managed with active surveillance.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Survival Analysis
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

